Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to extend cash

.Turnstone Biologics is lowering its own head count through 60% and also agitating its C-suite in or...

Gilead loses hope on $15M MASH bet after mulling preclinical information

.In a year that has found a confirmation and also a boating of readouts for metabolic dysfunction-as...

Texas biotech centers cancer pact, pins really hopes on obesity

.Alaunos Therapies is actually axing an agreement with Precigen, losing hope licensing civil rights ...

Capricor allotments even more data for DMD therapy after starting BLA

.Capricor Rehabs is taking a victory tour for their phase 2 Duchenne muscular dystrophy (DMD) test. ...

FDA spots Kezar lupus test in grip observing 4 patient deaths

.The FDA has actually positioned Kezar Life Sciences' lupus trial on grip after the biotech hailed 4...

Phase 3 Academic Rock trial reaches SMA objective, sending stock up 200%

.A period 3 trial of Historian Rock's vertebral muscle atrophy (SMA) prospect has actually attacked ...

CAMP 4 is newest to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Therapies has actually marked out think about a $67 million IPO, along with infla...

Galecto purchases leukemia medication, loses bone cancer resource in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect sent out Galecto on a hunt for s...

Judo tosses down $100M to knock senseless kidney illness

.Taking the mat is actually Judo Bio, a promising biotech equipped with $one hundred thousand to est...

AstraZeneca pays for CSPC $100M for preclinical heart disease drug

.AstraZeneca has settled CSPC Drug Group $100 thousand for a preclinical heart attack drug. The offe...